NASDAQ: PTHLPheton Holdings Ltd Stock
$0.75+0.03 (+4.17%)
Updated Aug 28, 2025
PTHL Price
$0.75
Fair Value Price
$0.42
Market Cap
$10.70M
52 Week Low
$0.51
52 Week High
$32.00
P/E
-14.44x
P/B
1.73x
P/S
125.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$448.20k
Earnings
-$660.59k
Gross Margin
85%
Operating Margin
-142.52%
Profit Margin
-147.4%
Debt to Equity
0.09
Operating Cash Flow
-$775k
Beta
0.53
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PTHL Overview
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PTHL's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important PTHL news, forecast changes, insider trades & much more!
PTHL News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PTHL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PTHL ($0.75) is overvalued by 79.44% relative to our estimate of its Fair Value price of $0.42 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PTHL ($0.75) is not significantly undervalued (79.44%) relative to our estimate of its Fair Value price of $0.42 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PTHL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PTHL due diligence checks available for Premium users.
Valuation
PTHL fair value
Fair Value of PTHL stock based on Discounted Cash Flow (DCF)
Price
$0.75
Fair Value
$0.42
Overvalued by
79.20%
PTHL ($0.75) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PTHL ($0.75) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PTHL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PTHL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-14.44x
Industry
32.11x
Market
35.78x
PTHL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.73x
Industry
4.04x
PTHL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PTHL's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
PTHL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PTHL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.7M
Liabilities
$538.6k
Debt to equity
0.09
PTHL's short-term assets ($6.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PTHL's short-term assets ($6.68M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PTHL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
PTHL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PTHL vs Medical Device Stocks
Pheton Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.